Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05393_nanopub.RA3J4KlZP-_Ey6N3INfuO8yOmfhebrt1LSPUmQ56-FDKA#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05393 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05393 label "NOV-002 [drugbank:DB05393]" assertion.
- drugbank:DB05393 seeAlso DB05393 assertion.
- drugbank:DB05393 description "NOV-002, the lead compound acts as a chemoprotectant and an immunomodulator, in combination with chemotherapy. NOV-002 is approved and marketed in the Russian Fereration by Pharma BAM under the trade name Glutoxim. It has been administered to over 10,000 patients, demonstrating clinical efficacy and excellent safety data." assertion.
- drugbank:DB05393 identifier "drugbank:DB05393" assertion.
- drugbank:DB05393 title "NOV-002" assertion.
- drugbank:DB05393 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05393 drugbank_vocabulary:drugbank-id "DB05393" assertion.
- drugbank:DB05393 bio2rdf_vocabulary:x-identifiers.org DB05393 assertion.
- drugbank:DB05393 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05393" assertion.
- drugbank:DB05393 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05393 bio2rdf_vocabulary:identifier "DB05393" assertion.